Romison Rodrigues Mota – Director, ANVISA
Dr. Rodrigues Mota brings two decades of leadership experience within ANVISA, the Brazilian Health Regulatory Authority, where he has held multiple senior positions and now serves as a key architect…
Address: R. Cônego Felipe, 365 – Taquara – Rio de Janeiro – RJ
Tel: (21) 2159-2600
Web: http://www.bago.com.br/web/cgi/cgilua.exe/sys/start.htm?tpl=home
With an innovative profile, Bagó Group is a leader in healthcare in Latin America. It is formed by a pool of solid enterprises, oriented around healthcare and improving quality of life.
Proud to be Latin American, the group was founded in 1934 in Argentina, and today is one of the most significant in the world pharmaceutical market. With an outstanding presence in Latin America and extending its roots over the world, it counts on over 6500 employees that share the same values of innovation and the same ideals of growth.
Laboratórios Bagó was established in Brazil in 2002, with the aim of working in the pharmaceutical industry as a tool for building a strong laboratory, and now counts a multidisciplinary team composed by over 180 professionals.
It is an intellectual leader, a reference in the Marketing business and has worked with Merck, Glaxo and Roche Laboratories.
Hydrophilic Array, Trifamox IBL, Magnesium Valproate, Alprazolam Sublingual, Talniflumate
Dr. Rodrigues Mota brings two decades of leadership experience within ANVISA, the Brazilian Health Regulatory Authority, where he has held multiple senior positions and now serves as a key architect…
Some of the top recent stories out of Latin America’s dynamic pharmaceutical and healthcare market. In Mexico, President Claudia Sheinbaum announced new investments from four leading Mexican pharmas totalling USD…
After a globe-trotting career that led him to diverse global affiliates, the long-term Takeda executive Rodrigo Rodriguez is going full circle. Returning to where he began his career at the…
A roundup of the biggest stories from Brazil’s pharma industry, including Teuto’s cannabis manufacturing deal with MediPharm; Eurofarma’s AI-based epilepsy joint venture with SK Biopharmaceuticals; EMS’s increased stake in Hypera…
With the largest public healthcare system in the world, Latin America’s biggest pharma market, its leading regulatory body, and a huge and diverse population, Brazil is a strategic destination for…
For the second consecutive year, DIA Europe hosted a Latin America Town Hall, a panel discussion to foster collaboration and share updates from regulatory activities in Latin America and Europe,…
An overview of some of the biggest stories from Latin American pharma and healthcare, including Brazil’s rollout of dengue vaccines following a sharp increase in cases; the Brazilian regulatory agency…
A roundup of some of the latest stories from Latin American pharma and healthcare, including Sanfer’s acquisition of Columbia-based injectables manufacturer Vitalis; medicine shortages in Colombia, and Chile’s move towards…
Brazil’s ANVISA is commonly recognised as LatAm’s leading national medicines regulator and is defined by the Pan American Health Organization (PAHO) as a National Regulatory Authority of Regional Reference (NRAr) for medicines…
The latest pharma news from Brazil, including the partnership between Biophytis and Innovation Solutions Pharma; Merck’s 100 years in Brazil; Eurofarma’s USD 100 million biotech investment, and GSK’s green light…
A roundup of some of the latest news from Latin American pharma, including Acino’s acquisition of M8 Pharmaceuticals; AstraZeneca’s growth in Mexico; Neuraxpharm’s expansion into Brazil and Mexico, and Columbia’s…
The DIA Global Annual Meeting 2023 hosted DIA’s first regulatory Town Hall fully dedicated to one regulator from Latin America, as leadership from Brazil’s Health Regulatory Agency, ANVISA, shared updates on the…
See our Cookie Privacy Policy Here
